Clinical Trial Update: Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered Drugs. [Phase 1]

View source ↗

Summary

Phase 1 open-label drug-drug interaction study of Radiprodil in the treatment of Tuberous Sclerosis Complex and Focal Cortical Dysplasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Focal Cortical Dysplasia
• Tuberous Sclerosis Complex

Drugs mentioned

• Radiprodil (Radiprodil)

Snippet

Sponsor: GRIN Therapeutics, Inc. | Conditions: Tuberous Sclerosis Complex (TSC), Focal Cortical Dysplasia | Phase 1 | Status: COMPLETED